Arkolith/Insider Trading/EWTX/Form 4

Russell Alan J

Chief Scientific Officer, DirectorEdgewise Therapeutics, Inc. (EWTX) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7.9M
Net Open-Market Flow
-$7.9M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)130K$0.45$59K155K
Jul 1, 2026Option exercise(M)70K$0.18$13K225K
Jul 1, 2026Sell(S)130K$39.41$5.1M94K
Jul 1, 2026Sell(S)70K$39.41$2.7M25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)130K—$00
Jul 1, 2026Option exercise(M)70K—$01.1M

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001853529-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML